Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Long-Term Capital Lease Obligation : ¥145 Mil (As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Zhangzhou Pientzehuang Pharmaceutical Co Long-Term Capital Lease Obligation?

Zhangzhou Pientzehuang Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥145 Mil.

Zhangzhou Pientzehuang Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (¥111 Mil) to Dec. 2024 (¥155 Mil) but then declined from Dec. 2024 (¥155 Mil) to Mar. 2025 (¥145 Mil).

Zhangzhou Pientzehuang Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (¥109 Mil) to Dec. 2023 (¥107 Mil) but then increased from Dec. 2023 (¥107 Mil) to Dec. 2024 (¥155 Mil).

Zhangzhou Pientzehuang Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Zhangzhou Pientzehuang Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhangzhou Pientzehuang Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Zhangzhou Pientzehuang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

106.48

86.67

108.80

107.29

154.58

Zhangzhou Pientzehuang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															114.50	108.95	111.00	154.58	144.66

Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Zhangzhou Pientzehuang Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zhangzhou Pientzehuang Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhangzhou Pientzehuang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhangzhou Pientzehuang Pharmaceutical Co Ltd (SHSE:600436) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Hupo Road, Xiangcheng District, Fujian Province, Zhangzhou, CHN, 363000

Website

https://www.zzpzh.com

Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).

Executives

Wei Teng Yun

Supervisors

Zhangzhou Pientzehuang Pharmaceutical Co Headlines

No Headlines